CLIA Waiver Authority Shifts To FDA; IVD Office Ready To Test New Methods
This article was originally published in The Gray Sheet
Executive Summary
CDRH is encouraging manufacturers to work with its in vitro diagnostics office to pilot new ways to meet CLIA waiver criteria